Breaking News Instant updates and real-time market news.

NEOG

Neogen

$63.28

0.73 (1.17%)

08:53
12/01/16
12/01
08:53
12/01/16
08:53

Neogen acquires U.K.-based Quat-Chem

Neogen has acquired United Kingdom-based Quat-Chem, a chemical company specializing in the development, manufacture and sale of agricultural, industrial, and food processing biocidal hygiene products, including cleaners and disinfectants. Terms of the current agreement were not disclosed. Quat-Chem Ltd. is a 20-year-old private company that manufactures a full line of complete disinfectant and cleaner products for dairy hygiene and poultry and swine biosecurity applications. Quat-Chem's annual revenues are approximately $12M. Quat-Chem is headquartered in an accredited, recently expanded facility in Rochdale, England, near Manchester, and its operations will be managed by Neogen's Scotland-based Neogen Europe subsidiary.

NEOG Neogen
$63.28

0.73 (1.17%)

03/24/16
ROTH
03/24/16
NO CHANGE
ROTH
Neogen should be bought on weakness, says Roth Capital
Roth Capital believes that Neogen is generating "rapid organic sales growth" which is being masked by adverse currency and sales mix trends. The firm expects the latter negative trends to significantly improve in the next few quarters, and it thinks the company has meaningful growth opportunities ahead. Roth recommends buying the stock on weakness and keeps a $68 price target and Buy rating on the shares.
07/25/16
ROTH
07/25/16
NO CHANGE
Target $68
ROTH
Buy
Neogen remains 'well positioned' to sustain rapid growth, says Roth Capital
Roth Capital analyst Anton Brenner believes Neogen remains "well positioned" to sustain rapid growth. While currency translation again adversely affected results in Q4 and some carryover to 2017 is likely, the analyst looks for sustained double-digit revenue growth and margin improvement over the next several years. Implementation of the Food Safety Modernization Act should be a significant tailwind, Brenner tells investors in a research note. He reiterates a Buy rating and $68 price target on the shares.
09/22/16
ROTH
09/22/16
NO CHANGE
Target $68
ROTH
Buy
Roth Capital remains a buyer of Neogen ahead of earnings
Roth Capital analyst Anton Brenner says that while adverse currency translation and a sales mix shift should adversely affect income comparisons in Q1, these short-term considerations should not undermine Neogen's extremely attractive outlook. The analyst expects that the implementation of the Food Safety Modernization Act and increasing food safety considerations in developing international markets will generate sustained double-digit revenue growth and improving profit margins over the next several years. He reiterates a Buy rating and $68 price target on Neogen's shares.
09/28/16
ROTH
09/28/16
NO CHANGE
Target $68
ROTH
Buy
Neogen outlook remains attractive, says Roth Capital
Roth Capital analyst Anton Brenner believes that while adverse currency translation and the removal of a product from the market adversely affected comparisons in Q1, Neogen's outlook for rapid growth remains intact. Moreover, he expects that the implementation of the Food Safety Modernization Act and increasing food safety considerations in developing international markets, in addition to periodic acquisitions, will generate sustainable double-digit revenue growth and improving profit margins over the next several years. The analyst reiterates a Buy rating and $68 price target on the shares.

TODAY'S FREE FLY STORIES

10:50
02/27/17
02/27
10:50
02/27/17
10:50
General news
U.S. Dallas Fed manufacturing index rose 2.4 points to 24.5 in February »

U.S. Dallas Fed…

HBI

Hanesbrands

$20.60

-0.78 (-3.65%)

10:47
02/27/17
02/27
10:47
02/27/17
10:47
Technical Analysis
Hanesbrands drops, levels to watch »

The shares were last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

10:45
02/27/17
02/27
10:45
02/27/17
10:45
General news
Treasury Action: already elevated yields inched up further »

Treasury Action: already…

10:45
02/27/17
02/27
10:45
02/27/17
10:45
General news
Breaking General news story  »

Dallas Federal Reserve…

SPKE

Spark Energy

$27.25

1.7 (6.65%)

10:44
02/27/17
02/27
10:44
02/27/17
10:44
Recommendations
Spark Energy analyst commentary  »

Janney says Spark Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Mar

10:44
02/27/17
02/27
10:44
02/27/17
10:44
General news
Dallas Fed Mfg Survey Production Index data reported »

February Dallas Fed Mfg…

UPS

UPS

$105.88

-0.3 (-0.28%)

10:41
02/27/17
02/27
10:41
02/27/17
10:41
Options
Opening action in UPS downside puts »

Opening action in UPS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

10:37
02/27/17
02/27
10:37
02/27/17
10:37
General news
Dallas Fed Mfg Survey Production Index data reported »

February Dallas Fed Mfg…

TVPT

Travelport

$12.88

-0.06 (-0.46%)

10:33
02/27/17
02/27
10:33
02/27/17
10:33
Conference/Events
Travelport management to meet with Evercore ISI »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

PGNX

Progenics

$10.36

0.12 (1.17%)

10:32
02/27/17
02/27
10:32
02/27/17
10:32
Conference/Events
Progenics management to meet with Aegis »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

  • 09

    Mar

ORIT

Oritani Financial

$17.15

-0.05 (-0.29%)

10:31
02/27/17
02/27
10:31
02/27/17
10:31
Conference/Events
Oritani Financial management to meet with Sandler O'Neill »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

  • 02

    Mar

  • 15

    May

X

U.S. Steel

$37.37

0.355 (0.96%)

10:31
02/27/17
02/27
10:31
02/27/17
10:31
Options
Bullish short-term option play in US Steel as shares see strength »

Bullish short-term option…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIP

VimpelCom

$4.30

-0.04 (-0.92%)

10:30
02/27/17
02/27
10:30
02/27/17
10:30
Earnings
VimpelCom reports Q4 EBITDA $783M »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MMS

Maximus

$60.41

0.1049 (0.17%)

10:30
02/27/17
02/27
10:30
02/27/17
10:30
Conference/Events
Maximus management to meet with Maxim »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 01

    Mar

  • 02

    Mar

10:29
02/27/17
02/27
10:29
02/27/17
10:29
General news
Market little changed in early trading as investors await Trump address »

Stock futures drifted…

CTSO

CytoSorbents

$5.60

0.05 (0.90%)

10:28
02/27/17
02/27
10:28
02/27/17
10:28
Conference/Events
CytoSorbents management to meet with B. Riley »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

  • 03

    Mar

VIP

VimpelCom

$4.30

-0.04 (-0.92%)

10:27
02/27/17
02/27
10:27
02/27/17
10:27
Hot Stocks
VimpelCom introduces new dividend policy »

VimpelCom introduces a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CL

Colgate-Palmolive

$72.93

-0.42 (-0.57%)

10:26
02/27/17
02/27
10:26
02/27/17
10:26
Options
Colgate Palmolive call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BP

BP

$33.77

0.265 (0.79%)

10:25
02/27/17
02/27
10:25
02/27/17
10:25
Conference/Events
BP management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

  • 06

    Mar

10:25
02/27/17
02/27
10:25
02/27/17
10:25
General news
Treasury Action: yields remained above lows »

Treasury Action: yields…

BAH

Booz Allen

$36.13

0.205 (0.57%)

10:24
02/27/17
02/27
10:24
02/27/17
10:24
Conference/Events
Booz Allen management to meet with Drexel Hamilton »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

VCYT

Veracyte

$7.95

0.06 (0.76%)

10:23
02/27/17
02/27
10:23
02/27/17
10:23
Hot Stocks
Veracyte: Data show potential for non-invasive test to improve cancer diagnosis »

Veracyte announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

AXP

American Express

$79.75

-0.01 (-0.01%)

, GOOG

Alphabet

$828.64

-2.69 (-0.32%)

10:23
02/27/17
02/27
10:23
02/27/17
10:23
Hot Stocks
American Express says doesn't have a 'deep' partnership with Google right now »

Says Marriott (MAR) has…

AXP

American Express

$79.75

-0.01 (-0.01%)

GOOG

Alphabet

$828.64

-2.69 (-0.32%)

MAR

Marriott

$87.08

0.08 (0.09%)

HOT

Starwood

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 27

    Feb

  • 06

    Mar

  • 19

    Mar

AAN

Aaron's

$27.23

0.05 (0.18%)

10:22
02/27/17
02/27
10:22
02/27/17
10:22
Conference/Events
Aaron's management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 01

    Mar

10:20
02/27/17
02/27
10:20
02/27/17
10:20
General news
FX Action: USD-CAD »

FX Action: USD-CAD traded…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.